Free Trial

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Clarivate Plc stock logo
CCC
Clarivate
$0.02
$29.06
$15.00
$33.55
$12.12M0.531.24 million shs19,871 shs
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
$3.52
+3.5%
$3.65
$2.70
$7.37
$230.12M1.0323,135 shs26,478 shs
SXS
3798 (SXS.V)
C$0.00
C$0.00
C$0.00
N/AN/AN/AN/A
(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Clarivate Plc stock logo
CCC
Clarivate
0.00%0.00%0.00%0.00%0.00%
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
0.00%-3.30%+1.15%+8.64%-9.97%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Clarivate Plc stock logo
CCC
Clarivate
1.3452 of 5 stars
0.00.00.03.80.00.82.5
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
2.1192 of 5 stars
3.44.00.00.01.10.00.6
SXS
3798 (SXS.V)
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Clarivate Plc stock logo
CCC
Clarivate
0.00
N/AN/AN/A
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
2.75
Moderate Buy$6.5084.66% Upside
SXS
3798 (SXS.V)
0.00
N/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Clarivate Plc stock logo
CCC
Clarivate
$974.34M0.01$0.00 per share29.97$4.43 per share0.00
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
$62.37M3.69N/AN/A$1.74 per share2.02
SXS
3798 (SXS.V)
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Clarivate Plc stock logo
CCC
Clarivate
-$210.98M$0.35N/A0.03N/A-18.75%7.92%3.39%N/A
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
-$78.98M-$1.09N/AN/AN/A-110.71%-55.06%-38.33%3/4/2025 (Estimated)
SXS
3798 (SXS.V)
N/AN/A0.00N/AN/AN/AN/AN/AN/A

Latest RSW, SXS, SOPH, and CCC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2024Q3 2024
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
-$0.24-$0.28-$0.04-$0.28$15.90 million$15.85 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Clarivate Plc stock logo
CCC
Clarivate
N/AN/AN/AN/AN/A
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
N/AN/AN/AN/AN/A
SXS
3798 (SXS.V)
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Clarivate Plc stock logo
CCC
Clarivate
0.81
1.42
1.42
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
0.12
3.80
4.17
SXS
3798 (SXS.V)
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Clarivate Plc stock logo
CCC
Clarivate
42.83%
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
31.59%
SXS
3798 (SXS.V)
N/A

Insider Ownership

CompanyInsider Ownership
Clarivate Plc stock logo
CCC
Clarivate
2.32%
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
4.88%
SXS
3798 (SXS.V)
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Clarivate Plc stock logo
CCC
Clarivate
4,090605.96 millionN/ANot Optionable
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
52065.38 million62.19 millionNot Optionable
SXS
3798 (SXS.V)
147,000N/AN/ANot Optionable

RSW, SXS, SOPH, and CCC Headlines

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Clarivate logo

Clarivate

NYSE:CCC
Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.
SOPHiA GENETICS logo

SOPHiA GENETICS

NASDAQ:SOPH
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.

3798 (SXS.V)

CVE:SXS
Solimar Energy Limited (Solimar) is an Australia-based oil and gas production and exploration company. The Company has a multi-project asset base focused in the oil prolific San Joaquin Basin, onshore California. The Company's assets are mainly in oil prone trends adjacent giant fields and target both conventional (sandstone) and unconventional (fractured oil shale) reservoirs. Solimar is engaged in conversion of an oil and gas resource potential within its acreage to reserves. The Company operates most of its assets, holding high equity positions. This includes a control position in the Kreyenhagen oil field with significant volumes of oil intersected by numerous wells within the Company's control acreage. The Company's projects include Kreyenhagen, Bayswater, Jacalitos, SELH, Paloma and Tejon Footwall. The Company's subsidiaries include Solimar Australia Energy Pty Ltd and Livingstone Energy Inc.